Amberjack Capital Fund II, L.P.'s Form 4 filing
Innovex International, Inc. (INVX) · filed Feb 27, 2026
- Accession no.
- 0001315863-26-000229
- Filed
- Feb 27, 2026, 8:14 PM ET
- Trade date
- Feb 27, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $162.6M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amberjack Capital Fund II, L.P.CIK 0001944811 | Director, 10% Owner |
| Innovex Co-Invest Fund II, L.P.CIK 0001958403 | Director, 10% Owner |
| Turowsky JasonCIK 0002025157 | Director, 10% Owner |
| Amberjack Management, LLCCIK 0002026020 | Director, 10% Owner |
| Innovex Co-Invest Associates, LLCCIK 0002026027 | Director, 10% Owner |
| Innovex Co-Invest Fund II GP, L.P.CIK 0002026028 | Director, 10% Owner |
| Amberjack Capital Associates II, LLCCIK 0002026029 | Director, 10% Owner |
| Amberjack Capital GP II, L.P.CIK 0002026032 | Director, 10% Owner |
| Amberjack Capital Partners, L.P.CIK 0002026035 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | SSaleDisposed | −4,902,244 | $24.59F1,F7,F8,F9,F10 | −$120,552,552.88 | 16,871,374 | Indirect | Duplicate filing |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −1,144,635 | $24.59F2,F7,F8,F9,F10 | −$28,148,062.68 | 3,939,330 | Indirect | Duplicate filing |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −271,279 | $24.59F3,F7,F8,F9,F10 | −$6,671,103.27 | 933,624 | Indirect | Duplicate filing |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −234,009 | $24.59F4,F7,F8,F9,F10 | −$5,754,585.52 | 805,355 | Indirect | Duplicate filing |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −116 | $24.59F5,F7,F8,F9,F10 | −$2,852.59 | 399 | Indirect | Duplicate filing |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −60,217 | $24.59F6,F7,F8,F9,F10 | −$1,480,814.31 | 207,240 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F2
Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F3
Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F4
Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F5
Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F6
Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
Referenced by the price of 1 transaction in Table I.
- F7
The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
Referenced by the price of 6 transactions in Table I.
- F8
(Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
Referenced by the price of 6 transactions in Table I.
- F9
By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
Referenced by the price of 6 transactions in Table I.
- F10
(Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Referenced by the price of 6 transactions in Table I.
Remarks
This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Innovex Co-Invest Fund, L.P.